Cormorant Asset Management, LP is a life sciences and healthcare focused investment firm, founded by Bihua Chen in 2013. Cormorant primarily invests in biotechnology companies across the public and private markets.
Cormorant employs a long-term, fundamental, and research-intensive approach grounded in deep scientific and therapeutic analysis. Our investment process prioritizes understanding the drugs, technologies, business models, and competitive landscape of public and private biotechnology and life sciences companies. We seek to identify opportunities where our research may lead to a differentiated view relative to market consensus. Cormorant is headquartered in Boston, Massachusetts.
